Retinai

About:

RetinAI optimises and simplifies clinics, research and pharmaceutical workflows to improve healthcare.

Website: http://www.retinai.com

Twitter/X: retin_ai

Top Investors: Verve Ventures, Venture Kick, Zürcher Kantonal Bank, b2venture, Eurostars

Description:

RetinAI optimises and simplifies clinics, research and pharmaceutical workflows to improve healthcare. To achieve this goal, the company builds tools to collect, analyze and organize health data, empowering healthcare professionals and patients with automatic image and data analysis supported by advanced machine learning. RetinAI has proprietary technology that provides unforeseen image quality enhancement, as well as automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies and device manufacturers at similar level of performance as a human would produce.

Total Funding Amount:

15.1M CHF

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Bern, Bern, Switzerland

Founded Date:

2016-12-16

Contact Email:

info(AT)retinai.com

Founders:

Carlos Ciller, Sandro Zanet, Stefanos Apostolopoulos

Number of Employees:

11-50

Last Funding Date:

2024-10-16

IPO Status:

Private

© 2024 MyAiNote.com